Glenmark Pharmaceuticals has informed that it attached media release on February 09,2021 titled ‘Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for the Treatment of Adult Patients with COVID-19 in partnership with SaNOtiz’.
The above information is a part of company’s filings submitted to BSE.